130 related articles for article (PubMed ID: 38854919)
1. Digitally managing depression: A fully remote randomised attention-placebo controlled trial.
Kandola A; Edwards K; Muller MA; Dührkoop B; Hein B; Straatman J; Hayes JF
Digit Health; 2024; 10():20552076241260409. PubMed ID: 38854919
[TBL] [Abstract][Full Text] [Related]
2. Digital Self-Management Platform for Adult Asthma: Randomized Attention-Placebo Controlled Trial.
Kandola A; Edwards K; Straatman J; Dührkoop B; Hein B; Hayes J
J Med Internet Res; 2024 Apr; 26():e50855. PubMed ID: 38684084
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial.
Lewis G; Duffy L; Ades A; Amos R; Araya R; Brabyn S; Button KS; Churchill R; Derrick C; Dowrick C; Gilbody S; Fawsitt C; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Khan N; Lanham P; Pervin J; Peters TJ; Riozzie D; Salaminios G; Thomas L; Welton NJ; Wiles N; Woodhouse R; Lewis G
Lancet Psychiatry; 2019 Nov; 6(11):903-914. PubMed ID: 31543474
[TBL] [Abstract][Full Text] [Related]
5. Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial.
Barkham M; Saxon D; Hardy GE; Bradburn M; Galloway D; Wickramasekera N; Keetharuth AD; Bower P; King M; Elliott R; Gabriel L; Kellett S; Shaw S; Wilkinson T; Connell J; Harrison P; Ardern K; Bishop-Edwards L; Ashley K; Ohlsen S; Pilling S; Waller G; Brazier JE
Lancet Psychiatry; 2021 Jun; 8(6):487-499. PubMed ID: 34000240
[TBL] [Abstract][Full Text] [Related]
6. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
7. Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCT.
Wilson JA; Stocken DD; Watson GC; Fouweather T; McGlashan J; MacKenzie K; Carding P; Karagama Y; Harries M; Ball S; Khwaja S; Costello D; Wood R; Lecouturier J; O'Hara J
Health Technol Assess; 2021 Jan; 25(3):1-118. PubMed ID: 33492208
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported outcome measures for monitoring primary care patients with depression: the PROMDEP cluster RCT and economic evaluation.
Kendrick T; Dowrick C; Lewis G; Moore M; Leydon GM; Geraghty AW; Griffiths G; Zhu S; Yao GL; May C; Gabbay M; Dewar-Haggart R; Williams S; Bui L; Thompson N; Bridewell L; Trapasso E; Patel T; McCarthy M; Khan N; Page H; Corcoran E; Hahn JS; Bird M; Logan MX; Ching BCF; Tiwari R; Hunt A; Stuart B
Health Technol Assess; 2024 Mar; 28(17):1-95. PubMed ID: 38551155
[TBL] [Abstract][Full Text] [Related]
9. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial.
Goldstein LH; Robinson EJ; Mellers JDC; Stone J; Carson A; Reuber M; Medford N; McCrone P; Murray J; Richardson MP; Pilecka I; Eastwood C; Moore M; Mosweu I; Perdue I; Landau S; Chalder T;
Lancet Psychiatry; 2020 Jun; 7(6):491-505. PubMed ID: 32445688
[TBL] [Abstract][Full Text] [Related]
10. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
[TBL] [Abstract][Full Text] [Related]
11. Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial.
Collins SE; Duncan MH; Saxon AJ; Taylor EM; Mayberry N; Merrill JO; Hoffmann GE; Clifasefi SL; Ries RK
Lancet Psychiatry; 2021 Apr; 8(4):287-300. PubMed ID: 33713622
[TBL] [Abstract][Full Text] [Related]
12. Assessment of a home-based standing frame programme in people with progressive multiple sclerosis (SUMS): a pragmatic, multi-centre, randomised, controlled trial and cost-effectiveness analysis.
Freeman J; Hendrie W; Jarrett L; Hawton A; Barton A; Dennett R; Jones B; Zajicek J; Creanor S
Lancet Neurol; 2019 Aug; 18(8):736-747. PubMed ID: 31301748
[TBL] [Abstract][Full Text] [Related]
13. Preliminary Efficacy of a Digital Intervention for Adolescent Depression: Randomized Controlled Trial.
Peake E; Miller I; Flannery J; Chen L; Lake J; Padmanabhan A
J Med Internet Res; 2024 Feb; 26():e48467. PubMed ID: 38324367
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
[TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
[TBL] [Abstract][Full Text] [Related]
16. Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Young T; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Julious SA; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude E; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Bouhassira D; Bennett DL; Selvarajah D
Health Technol Assess; 2022 Oct; 26(39):1-100. PubMed ID: 36259684
[TBL] [Abstract][Full Text] [Related]
17. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
18. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
[TBL] [Abstract][Full Text] [Related]
19. Digital interventions for the management of chronic obstructive pulmonary disease.
Janjua S; Banchoff E; Threapleton CJ; Prigmore S; Fletcher J; Disler RT
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013246. PubMed ID: 33871065
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
